Glenmark, Solar Pharma, Zydus recall medicines in US over manufacturing points

One other Indian pharma firm, Solar Pharmaceutical Industries, can be recalling a product within the US. Its US-based unit, Solar Pharmaceutical Industries Inc., has recalled round 13,700 bottles of Gabapentin capsules.

These capsules are used to deal with and forestall seizures in individuals with epilepsy. The recall was initiated as a result of considerations of ‘cross-contamination.’

This Class III recall began on 4 March 2025. A Class III recall is taken into account the least critical and is made when using a product isn’t prone to trigger hurt.

In the meantime, Zydus Prescription drugs (USA) Inc., a subsidiary of Zydus, is recalling 3,144 bottles of Chlorpromazine Hydrochloride Tablets.

These tablets are used for treating psychological well being situations similar to schizophrenia and bipolar dysfunction.

The USFDA stated the recall was as a result of presence of an impurity, N-Nitroso-Desmethyl Chlorpromazine, discovered above the suitable restrict. The corporate started this Class II recall on 3 April.

The USFDA usually displays the protection and high quality of medicines offered within the US and ensures that drugmakers observe strict manufacturing requirements.